Skip to main content
Top
Published in: International Urology and Nephrology 3/2010

01-09-2010 | Nephrology - Case Report

Microscopic polyangiitis triggered by recurrent methicillin-resistant Staphylococcus aureus bacteremia

Authors: Rahil Kasmani, Kelechi Okoli, Kalpana Naraharisetty, William Gunning, Joseph I. Shapiro, Shobha Ratnam

Published in: International Urology and Nephrology | Issue 3/2010

Login to get access

Abstract

Most of the purported links between microbial agents and primary small-vessel anti-neutrophilic antibody-positive (ANCA) vasculitides remain speculative. There is strong circumstantial evidence for the role of Staphylococcus aureus in the development of Wegener’s granulomatosis, but its role in other ANCA-positive vasculitis syndromes is less clear. We describe a patient who developed a non-granulomatous, necrotizing small-vessel vasculitis with a positive anti-neutrophil cytoplasmic antibody of a perinuclear type (p-ANCA), along with anti-myeloperoxidase antibodies after recurrent episodes of methicillin-resistant Staphylococcus aureus bacteremia.
Literature
1.
go back to reference Stegeman CA, Cohen Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CGM (1994) Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 120(1):12–17PubMed Stegeman CA, Cohen Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CGM (1994) Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 120(1):12–17PubMed
2.
go back to reference DeRemee RA, McDonald TJ, Weiland LH (1985) Wegener’s granulomatosis: observations on treatment with antimicrobial agents. Mayo Clin Proc 60:27–32PubMed DeRemee RA, McDonald TJ, Weiland LH (1985) Wegener’s granulomatosis: observations on treatment with antimicrobial agents. Mayo Clin Proc 60:27–32PubMed
3.
go back to reference Hellmich B, Ehren M, Lindstaedt M, Meyer M, Pfohl M (2001) Schatz H: anti-MPO-ANCA-positive microscopic polyangiitis following subacute bacterial endocarditis. Clin Rheumatol 20:441–443CrossRefPubMed Hellmich B, Ehren M, Lindstaedt M, Meyer M, Pfohl M (2001) Schatz H: anti-MPO-ANCA-positive microscopic polyangiitis following subacute bacterial endocarditis. Clin Rheumatol 20:441–443CrossRefPubMed
4.
go back to reference Miranda-Filloy JA, Veiga JA, Juarez Y, Gonzalez-Juanatey C, Gonzalez-Gay MA, Garcia-Porrua C (2006) Microscopic polyangiitis following recurrent Staphylococcus aureus bacteremia and infectious endocarditis. Clin Exp Rheumatol 24(6):705–706PubMed Miranda-Filloy JA, Veiga JA, Juarez Y, Gonzalez-Juanatey C, Gonzalez-Gay MA, Garcia-Porrua C (2006) Microscopic polyangiitis following recurrent Staphylococcus aureus bacteremia and infectious endocarditis. Clin Exp Rheumatol 24(6):705–706PubMed
5.
go back to reference Davson J, Ball J, Platt R (1948) The kidney in periarteritis nodosa. Q J Med 17:175–202PubMed Davson J, Ball J, Platt R (1948) The kidney in periarteritis nodosa. Q J Med 17:175–202PubMed
6.
go back to reference Jennette JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 37:187–192CrossRefPubMed Jennette JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 37:187–192CrossRefPubMed
7.
go back to reference Kelley WN (1997) Vasculitis and related disorders. In: Textbook of rheumatology, 5th edn. Saunders, Philadelphia, pp 1079–1101 Kelley WN (1997) Vasculitis and related disorders. In: Textbook of rheumatology, 5th edn. Saunders, Philadelphia, pp 1079–1101
10.
11.
go back to reference van Wijngaarden RA, van Rijn L, Hagen EC et al (2008) Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known. Clin J Am Soc Nephrol 3(1):237–252CrossRef van Wijngaarden RA, van Rijn L, Hagen EC et al (2008) Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known. Clin J Am Soc Nephrol 3(1):237–252CrossRef
12.
go back to reference Zeledon JI, McKelvey RL, Servilla KS et al (2008) Glomerulonephritis causing acute renal failure during the course of bacterial infections. Histological varieties, potential pathogenetic pathways and treatment. Int Urol Nephrol 40(2):461–470CrossRefPubMed Zeledon JI, McKelvey RL, Servilla KS et al (2008) Glomerulonephritis causing acute renal failure during the course of bacterial infections. Histological varieties, potential pathogenetic pathways and treatment. Int Urol Nephrol 40(2):461–470CrossRefPubMed
13.
go back to reference Kon Y, Bohgaki M, Notoya A et al (2006) Microscopic polyangiitis triggered by fungal infection. Hokkaido Igaku Zasshi 81(1):5–8PubMed Kon Y, Bohgaki M, Notoya A et al (2006) Microscopic polyangiitis triggered by fungal infection. Hokkaido Igaku Zasshi 81(1):5–8PubMed
14.
go back to reference Cohen Tervaert JA, Popa RA, Bos NA (1999) The role of superantigens in vasculitis. Curr Opin Rheumatol 11:24–33CrossRef Cohen Tervaert JA, Popa RA, Bos NA (1999) The role of superantigens in vasculitis. Curr Opin Rheumatol 11:24–33CrossRef
15.
go back to reference George J, Levy Y, Kallenberg CG (1997) Shoenfeld Y: infections and Wegener’s granulomatosis: a cause and effect relationship? QJM 90:367–373CrossRefPubMed George J, Levy Y, Kallenberg CG (1997) Shoenfeld Y: infections and Wegener’s granulomatosis: a cause and effect relationship? QJM 90:367–373CrossRefPubMed
16.
go back to reference Pendergraft WF III, Preston GA, Shah RR et al (2004) Autoimmunity is triggered by cPR-3(105–201), a protein complementary to human autoantigen proteinase-3. Nat Med 10:72–79CrossRefPubMed Pendergraft WF III, Preston GA, Shah RR et al (2004) Autoimmunity is triggered by cPR-3(105–201), a protein complementary to human autoantigen proteinase-3. Nat Med 10:72–79CrossRefPubMed
17.
go back to reference Bautz DJ, Preston GA, Lionaki S et al (2008) Antibodies with dual reactivity to plasminogen and complementary PR3 in PR3-ANCA vasculitis. J Am Soc Nephrol 19(12):2421–2429CrossRefPubMed Bautz DJ, Preston GA, Lionaki S et al (2008) Antibodies with dual reactivity to plasminogen and complementary PR3 in PR3-ANCA vasculitis. J Am Soc Nephrol 19(12):2421–2429CrossRefPubMed
18.
go back to reference Yang J, Bautz DJ, Lionaki S et al (2008) ANCA patients have T cells responsive to complementary PR-3 antigen. Kidney Int 74(9):1159–1169CrossRefPubMed Yang J, Bautz DJ, Lionaki S et al (2008) ANCA patients have T cells responsive to complementary PR-3 antigen. Kidney Int 74(9):1159–1169CrossRefPubMed
19.
go back to reference Caputo A, Fahey D, Lloyd C, Vozab R, McCairns E, Rowe PB (1988) Structure and differential mechanisms of regulation of expression of a serine esterase gene in activated human T lymphocytes. J Biol Chem 263:6363–6369PubMed Caputo A, Fahey D, Lloyd C, Vozab R, McCairns E, Rowe PB (1988) Structure and differential mechanisms of regulation of expression of a serine esterase gene in activated human T lymphocytes. J Biol Chem 263:6363–6369PubMed
Metadata
Title
Microscopic polyangiitis triggered by recurrent methicillin-resistant Staphylococcus aureus bacteremia
Authors
Rahil Kasmani
Kelechi Okoli
Kalpana Naraharisetty
William Gunning
Joseph I. Shapiro
Shobha Ratnam
Publication date
01-09-2010
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 3/2010
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-009-9652-8

Other articles of this Issue 3/2010

International Urology and Nephrology 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.